Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer

Ovarian cancer treatment remains a challenge and targeting cancer stem cells presents a promising strategy. Niclosamide is an “old” antihelminthic drug that uncouples mitochondria of intestinal parasites. Although recent studies demonstrated that niclosamide could be a potential anticancer agent, it...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Lin, Chi-Kang, Bai, Meng-Yi, Hu, Teh-Min, Wang, Yu-Chi, Chao, Tai-Kuang, Weng, Shao-Ju, Huang, Rui-Lan, Su, Po-Hsuan, Lai, Hung-Cheng
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891020/
https://ncbi.nlm.nih.gov/pubmed/26848771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7113
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki